Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
ACRS

Aclaris Therapeutics, Inc. (ACRS)

NASDAQ
$3.62
-$0.29
(-7.27%)
Regular Market

Last updated: ⁦2026-11-16 16:42:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Aclaris Therapeutics, Inc. (ACRS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.62, with a market capitalization of $621.76M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.34 to $6.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$621.76M

$3.38

$3.80

$3.13

$3.92

5.77M

2.93M

--

$6.60

$2.34

--

--

Aclaris Therapeutics, Inc. (ACRS) Stock Price Today

Aclaris Therapeutics, Inc. (ACRS) is currently trading at $3.62 as of 2026-11-16 16:26:48, down 7.27% ($0.29) from the previous close of $3.92

During today's regular trading session, ACRS has traded between $3.13 and $3.80, with a trading volume of 5.77M shares. The current price is near the upper end of today's range.

Why Is ACRS Stock Up Today?

ACRS is up 4.22% during regular trading hours.

Aclaris Therapeutics shares are trading lower after the company announced that its Phase 2 ADMIRATION trial of bosakitug in atopic dermatitis missed its primary and secondary endpoints.

Source: Benzinga · Updated

Aclaris Therapeutics, Inc. (ACRS) 7-Day Stock Price Change

Over the past seven days, Aclaris Therapeutics, Inc. (ACRS) moved from $3.61 to $3.62, representing a gain of 0.14% ($0.01).

The stock traded between $3.13 and $4.40 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 2.05 million shares, down versus the previous seven-day period, indicating lower trading activity.

ACRS 52-Week Price Position

Position in Range: 29.9%

52W Low$2.34
52W High$6.60

ACRS is currently trading at $3.62, placing it 29.9% of the way from its 52-week low of $2.34 to its 52-week high of $6.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Aclaris Therapeutics, Inc. (ACRS)?

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.

Aclaris Therapeutics, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
73
Exchange
NASDAQ
Company Website

ACRS News

Latest news related to Aclaris Therapeutics, Inc. and ACRS stock.

  • Benzinga

    Why is Aclaris Therapeutics Stock Trading Lower on Monday?

    Aclaris Therapeutics misses Phase 2 bosakitug endpoints but launches its Phase 2b modzatinib trial for moderate-to-severe lichen planus.

    Read Full Article
  • Benzinga

    Aclaris Therapeutics, Summit Therapeutics And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

    U.S. stock futures fell as Aclaris plunged 21% after its dermatitis trial failed; Summit and other stocks also dropped in premarket trading.

    Read Full Article
  • Benzinga

    Why Take-Two Interactive Software Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

    Take-Two rose 4% ahead of GTA VI’s Nov. 19 release on strong presales. GreenPower led gainers, while Datavault AI plunged 43%.

    Read Full Article
  • Benzinga

    Aclaris Begins Phase 2b Modzatinib Trial In Lichen Planus, Fast Track-Designated Dual ITK/JAK3 Inhibitor With Potential As First Mechanistically Complete Oral Therapy

    - Dual Inhibition of ITK and JAK3 Provides Potential for Modzatinib to be the First Mechanistically Complete Oral Therapy for Lichen Planus, an Unaddressed Inflammatory Disease with No Approved Therapeutic Options --

    Read Full Article
  • Benzinga

    Aclaris Phase 2 ADMIRATION Trial Of Anti-TSLP Antibody Bosakitug In Atopic Dermatitis Misses Primary Endpoint Of EASI Percent Change At Week 24, Secondary Endpoints Also Not Met

    - The ADMIRATION Trial Did Not Achieve its Primary Endpoint of Percent Change in Eczema Area and Severity Index (EASI) Score from Baseline at Week 24 -- Aclaris Remains Focused on Prioritizing the Development of its

    Read Full Article

Ways to Trade ACRS at MEXC

ACRS MEXC RealStocks

Own real ACRS shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Aclaris Therapeutics, Inc. (ACRS) Stock on MEXC

Eligible investors can buy real shares of Aclaris Therapeutics, Inc. (ACRS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for ACRS and Place Your Order
Step 3: Search for ACRS and Place Your Order
Open the RealStocks trading page and search for ACRS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Aclaris Therapeutics, Inc. (ACRS) stock price today?
Aclaris Therapeutics, Inc. (ACRS) is currently trading at $3.62, down 7.27% ($0.29) from the previous close of $3.92. Intraday prices update in real time during regular trading hours.
2.Is ACRS stock going up or down today?
As of 2026-11-16 16:26:48, ACRS is trading at $3.62, down 7.27% ($0.29) from its previous close of $3.92. The stock has traded between $3.13 and $3.80 during today’s regular session. Past price movements do not guarantee future results.
3.What is ACRS pre-market price?
As of 2026-11-16 16:26:48, ACRS is trading at $3.45 in pre-market trading, down 12.07% ($0.47) from the previous close of $3.92. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is ACRS after-hours price?
As of 2026-11-16 16:26:48, ACRS is trading at $3.80 in after-hours trading, up 5.15% ($0.19) from the regular-session close of $3.62. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is ACRS stock trading now?
ACRS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does ACRS sit relative to its 52-week high and low?
Over the past 52 weeks, ACRS has traded between a low of $2.34 and a high of $6.60. At $3.62, the stock is positioned 29.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Aclaris Therapeutics, Inc. in?
Aclaris Therapeutics, Inc. (ACRS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Aclaris Therapeutics, Inc.'s market capitalization and where is it listed?
Aclaris Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $621.76M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is ACRS valued in terms of P/E ratio and EPS?
ACRS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.50. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Aclaris Therapeutics, Inc. pay a dividend?
Aclaris Therapeutics, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ACRS, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

ACRS Stock Calculator

Estimate the value between ACRS shares and USD.

ACRS Shares to USD

ACRS Shares
ACRS
ACRS
USD
USD
USD

1.00 ACRS shares = 3.615 USD

Calculations are estimates based on the latest available price and are for reference only.